Global Nucleic Acid Vaccine Market Research Report 2021

1 Nucleic Acid Vaccine Market Overview

• 1.1 Product Overview and Scope of Nucleic Acid Vaccine
• 1.2 Nucleic Acid Vaccine Segment by Type
  • 1.2.1 Global Nucleic Acid Vaccine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Preventive Nucleic Acid Vaccine
  • 1.2.3 Therapeutic Vucleic Acid Vaccine
• 1.3 Nucleic Acid Vaccine Segment by Application
  • 1.3.1 Nucleic Acid Vaccine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Nucleic Acid Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Nucleic Acid Vaccine Revenue 2016-2027
  • 1.4.2 Global Nucleic Acid Vaccine Sales 2016-2027
  • 1.4.3 Nucleic Acid Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nucleic Acid Vaccine Market Competition by Manufacturers

• 2.1 Global Nucleic Acid Vaccine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Nucleic Acid Vaccine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Nucleic Acid Vaccine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Nucleic Acid Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Nucleic Acid Vaccine Market Competitive Situation and Trends
  • 2.5.1 Nucleic Acid Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Nucleic Acid Vaccine Players Market Share by Revenue
  • 2.5.3 Global Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nucleic Acid Vaccine Retrospective Market Scenario by Region

• 3.1 Global Nucleic Acid Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Nucleic Acid Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Nucleic Acid Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Nucleic Acid Vaccine Sales by Country
  • 3.3.2 North America Nucleic Acid Vaccine Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Nucleic Acid Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Nucleic Acid Vaccine Sales by Country
  • 3.4.2 Europe Nucleic Acid Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Nucleic Acid Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Nucleic Acid Vaccine Sales by Region
  • 3.5.2 Asia Pacific Nucleic Acid Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Nucleic Acid Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Nucleic Acid Vaccine Sales by Country
  • 3.6.2 Latin America Nucleic Acid Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Nucleic Acid Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Nucleic Acid Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Nucleic Acid Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Nucleic Acid Vaccine Historic Market Analysis by Type

• 4.1 Global Nucleic Acid Vaccine Sales Market Share by Type (2016-2021)
• 4.2 Global Nucleic Acid Vaccine Revenue Market Share by Type (2016-2021)
• 4.3 Global Nucleic Acid Vaccine Price by Type (2016-2021)

5 Global Nucleic Acid Vaccine Historic Market Analysis by Application

• 5.1 Global Nucleic Acid Vaccine Sales Market Share by Application (2016-2021)
• 5.2 Global Nucleic Acid Vaccine Revenue Market Share by Application (2016-2021)
• 5.3 Global Nucleic Acid Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Moderna
  • 6.1.1 Moderna Corporation Information
  • 6.1.2 Moderna Description and Business Overview
  • 6.1.3 Moderna Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Moderna Product Portfolio
  • 6.1.5 Moderna Recent Developments/Updates
• 6.2 CureVac
  • 6.2.1 CureVac Corporation Information
  • 6.2.2 CureVac Description and Business Overview
  • 6.2.3 CureVac Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 CureVac Product Portfolio
  • 6.2.5 CureVac Recent Developments/Updates
• 6.3 Inovio
  • 6.3.1 Inovio Corporation Information
  • 6.3.2 Inovio Description and Business Overview
  • 6.3.3 Inovio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Inovio Product Portfolio
  • 6.3.5 Inovio Recent Developments/Updates
• 6.4 Sanofi
  • 6.4.1 Sanofi Corporation Information
  • 6.4.2 Sanofi Description and Business Overview
  • 6.4.3 Sanofi Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Sanofi Product Portfolio
  • 6.4.5 Sanofi Recent Developments/Updates
• 6.5 GSK
  • 6.5.1 GSK Corporation Information
  • 6.5.2 GSK Description and Business Overview
  • 6.5.3 GSK Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 GSK Product Portfolio
  • 6.5.5 GSK Recent Developments/Updates
• 6.6 CNBG
  • 6.6.1 CNBG Corporation Information
  • 6.6.2 CNBG Description and Business Overview
  • 6.6.3 CNBG Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 CNBG Product Portfolio
  • 6.6.5 CNBG Recent Developments/Updates
• 6.7 Hualan Bio
  • 6.6.1 Hualan Bio Corporation Information
  • 6.6.2 Hualan Bio Description and Business Overview
  • 6.6.3 Hualan Bio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Hualan Bio Product Portfolio
  • 6.7.5 Hualan Bio Recent Developments/Updates
• 6.8 Zhifei Shengwu
  • 6.8.1 Zhifei Shengwu Corporation Information
  • 6.8.2 Zhifei Shengwu Description and Business Overview
  • 6.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Zhifei Shengwu Product Portfolio
  • 6.8.5 Zhifei Shengwu Recent Developments/Updates
• 6.9 Liaoning Chengda
  • 6.9.1 Liaoning Chengda Corporation Information
  • 6.9.2 Liaoning Chengda Description and Business Overview
  • 6.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Liaoning Chengda Product Portfolio
  • 6.9.5 Liaoning Chengda Recent Developments/Updates
• 6.10 BioKangtai
  • 6.10.1 BioKangtai Corporation Information
  • 6.10.2 BioKangtai Description and Business Overview
  • 6.10.3 BioKangtai Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 BioKangtai Product Portfolio
  • 6.10.5 BioKangtai Recent Developments/Updates
• 6.11 CanSinoBIO
  • 6.11.1 CanSinoBIO Corporation Information
  • 6.11.2 CanSinoBIO Nucleic Acid Vaccine Description and Business Overview
  • 6.11.3 CanSinoBIO Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 CanSinoBIO Product Portfolio
  • 6.11.5 CanSinoBIO Recent Developments/Updates
• 6.12 Walvax Biotechnology
  • 6.12.1 Walvax Biotechnology Corporation Information
  • 6.12.2 Walvax Biotechnology Nucleic Acid Vaccine Description and Business Overview
  • 6.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Walvax Biotechnology Product Portfolio
  • 6.12.5 Walvax Biotechnology Recent Developments/Updates
• 6.13 Fosun Pharma
  • 6.13.1 Fosun Pharma Corporation Information
  • 6.13.2 Fosun Pharma Nucleic Acid Vaccine Description and Business Overview
  • 6.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Fosun Pharma Product Portfolio
  • 6.13.5 Fosun Pharma Recent Developments/Updates

7 Nucleic Acid Vaccine Manufacturing Cost Analysis

• 7.1 Nucleic Acid Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Nucleic Acid Vaccine
• 7.4 Nucleic Acid Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Nucleic Acid Vaccine Distributors List
• 8.3 Nucleic Acid Vaccine Customers

9 Nucleic Acid Vaccine Market Dynamics

• 9.1 Nucleic Acid Vaccine Industry Trends
• 9.2 Nucleic Acid Vaccine Growth Drivers
• 9.3 Nucleic Acid Vaccine Market Challenges
• 9.4 Nucleic Acid Vaccine Market Restraints

10 Global Market Forecast

• 10.1 Nucleic Acid Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Nucleic Acid Vaccine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Nucleic Acid Vaccine by Type (2022-2027)
• 10.2 Nucleic Acid Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Nucleic Acid Vaccine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Nucleic Acid Vaccine by Application (2022-2027)
• 10.3 Nucleic Acid Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Nucleic Acid Vaccine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Nucleic Acid Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List